Cargando…
Review of COVID-19 Vaccines and Their Evidence in Older Adults
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has resulted in a global pandemic and significant loss of life. Older people are vulnerable to SARS-CoV-2 infections and complications; thus, they are a priority group to receive COVID-19 v...
Autor principal: | Teo, Shyh Poh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Geriatrics Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024166/ https://www.ncbi.nlm.nih.gov/pubmed/33550776 http://dx.doi.org/10.4235/agmr.21.0011 |
Ejemplares similares
-
COVID-19 vaccine safety surveillance and emerging concerns of vaccine-induced immune thrombotic thrombocytopenia
por: Teo, Shyh Poh
Publicado: (2021) -
Ipsilateral Axillary Adenopathy from mRNA COVID-19 Vaccines
por: Teo, Shyh Poh
Publicado: (2021) -
Utility of Frailty Screening Tools in Older Surgical Patients
por: Poh, Alicia Wan Yan, et al.
Publicado: (2020) -
A Call to Enhance Active and Transparent Pharmacovigilance for COVID-19 Vaccines
por: Kunene, Khontile Nobuhle, et al.
Publicado: (2023) -
Interpretation of Antigen-detection Rapid Diagnostic Tests (Ag-RDTs) Should Take into Account the Pre-test Probability of COVID-19 Infection
por: Teo, Shyh Poh
Publicado: (2022)